[Enzyme substitution therapy in digestive system diseases with special consideration of patients treated with tuberculostatic agents].
D000995:Antitubercular Agents / Q000009:adverse effects / Q000627:therapeutic use; D001230:Aspergillus; D001660:Biliary Tract Diseases / Q000188:drug therapy*; D002756:Cholagogues and Choleretics / Q000627:therapeutic use; D005227:Fatty Acids / Q000097:blood; D005767:Gastrointestinal Diseases / Q000188:drug therapy; D006801:Humans; D010194:Pancreatin / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000150:complications / Q000188:drug therapy*
D000995:Antitubercular Agents; D002756:Cholagogues and Choleretics; D005227:Fatty Acids; D010194:Pancreatin
Die Enzym-Substitutionstherapie bei Erkrankungen der Verdauungsorgane unter besonderer Berücksichtigung von Patienten, die mit Tuberkulostatika behandelt wurden.